baber/WOPTO huggingface dataset:
Patent FI-965298-A0 (FI)
Inventor: RAUTIAINEN KARI
IPC: G01R15/14
Filed: 1996-12-31
Abstract: The invention relates to a lead-in insulator comprising a primary conductor (4) centrally led through the body (5) of the insulator, a current measuring element (3) arranged around the primary conductor, and a voltage measuring element (2), based on voltage division and arranged inside the current measuring element (3) concentrically therewith. In accordance with the invention the insulator further comprises a second voltage measuring element (1) for voltage detection, arranged substantially axially with respect to said voltage measuring element (2). <IMAGE>
Patent FI-970920-A0 (FI)
Inventor: DEGREGORIO MICHAEL
IPC: A61K31/565
Filed: 1997-03-04
Abstract: PCT No. PCT/FI95/00475 Sec. 371 Date Apr. 1, 1997 Sec. 102(e) Date Apr. 1, 1997 PCT Filed Sep. 6, 1995 PCT Pub. No. WO96/07402 PCT Pub. Date Mar. 14, 1996Compounds having formula (I) wherein R1 and R2 are independently H or OH, are useful in the treatment and prevention of osteoporosis. The compounds of formula (I) are devoid of significant antiestrogenic and estrogenic activity.    <IMAGE>  (I)
Patent FI-973281-A0 (FI)
Inventor: BELYK KEVIN M
IPC: C07K1/107
Filed: 1997-08-08
Abstract: There is disclosed a novel process for preparing aza cyclohexapeptides of the formula    <IMAGE>  (I)  where all variables are defined herein.
Patent FI-974534-A0 (FI)
Inventor: RANTA PEKKA
IPC: H04B7/08
Filed: 1997-12-16
Abstract: The inventive idea is to send in the same cell on one channel several signals and to cause different radio frequency characteristics to the signals received on the same channel. The different characteristics of signals are brought about e.g. by modulating the signals in different ways or by sending the signals from different points, whereby the different signals will experience different radio channels. Owing to the different characteristics, the signals can be distinguished from one another by a joint detection, interference cancellation method. In the downlink direction from base transceiver station to the mobile station and in the uplink direction from mobile station to the base transceiver station it is often advantageous to use different methods.
Patent FI-982598-A0 (FI)
Inventor: VIRKKI MARKKU
IPC: A23K50/10
Filed: 1998-12-01
Abstract: The invention relates to a method for testing a fodder component for the feeding of ruminants via ruminal fermentation simulation known in itself in an artificial rumen so that the fodder component is decomposed by the action of microbes into fermentation products utilizable in the animal's metabolism and providing the nutritive substances needed by the animal. In the method, fermentation products substantially proportional to the yield of the animal are measured and compared with corresponding results achieved using known fodder components whose productional effect is known. Based on the comparison, the effect of the fodder component on the animal's yield is determined.
Patent AP-9801261-A0 (AP)
Title: Farnesyl transferase inhibitors in combination with HMG COA reductase inhibitors for the treatment of cancer.
Inventor: KAJIJI SHAMA MOHAMMED
IPC: A61K31/405
Filed: 1998-06-11
Abstract: The present invention relates to a method of treating cancer in a mammal, including a human, by administering to the mammal a ftase inhibitor in combination with an hmg coa reductase inhibitor.
Patent IL-74921-A0 (IL)
Title: 4-(nitrophenyl)-tetrahydropyridines,their preparation and pharmaceutical compositions containing them
IPC: A61K31/44
Filed: 1985-04-16
Abstract: 4-(Nitrophenyl)-1,2,3,4-tetrahydropyridines of the formula    <IMAGE> (I)  in which R1 and R2 are identical or different and each represent hydrogen, phenyl or a straight-chain or branched alkyl radical which is optionally substituted by halogen or alkoxy, R3 represents a straight-chain or branched alkyl radical which is optionally substituted by alkoxy, halogen, alkylamino or aryl, X represents a single bond, an oxygen atom, a sulphur atom or the NH group and Y denotes either the nitrile group or the radical   <IMAGE>  wherein X' corresponds to the definition of X and can either be identical to X or different from X, and R4 corresponds to the definition of R3 and can be either identical to R3 or different from R3, or physiologically acceptable salts thereof, which are active on the circulation system, for example as vasodilators.
Patent IL-85607-A0 (IL)
Title: Low toxicity drug-lipid systems
IPC: A61K/
Filed: 1988-03-02
Abstract: Methods and compositions are described for nonliposomal lipid complexes in association with toxic hydrophobic drugs such as the polyene antibiotic amphotericin B. Lipid compositions are preferably a combination of the phospholipids dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) in about a 7:3 mole ratio. The lipid complexes contain a bioactive agent, and may be made by a number of procedures, at high drug:lipid ratios. These compositions of high drug:lipid complexes (HDLCs) may be administered to mammals such as humans for the treatment of infections, with substantially equivalent or greater efficacy and reduced drug toxicities as compared to the drugs in their free form. Also disclosed is a novel liposome-loading procedure, which may also be used in the formation of the HDLCs.
Patent IL-86952-A0 (IL)
Title: Synthesis of aminomethylene phosphonalkylphosphinates
IPC: C07F9/38
Filed: 1988-07-01
Abstract: The present invention involves processes for making aminomethylene phosphonoalkylphosphinate compounds comprising:   (a) heating a substantially anhydrous mixture comprising an amine, an ester of an alkyl phosphite, and an ester of a phosphate acetyl; and then   (b) adding water to the mixture. s
Patent IL-88464-A0 (IL)
Title: Set of concrete building blocks for constructing a dry wall
IPC: E02D29/02
Filed: 1988-11-23
Abstract: The set of concrete wall stones consists of front (1), anchoring (2) and connecting stones (3). The front stones (1) have a textured front side similar to natural stone and dovetailed projections (5) are integrally formed on their rear side. 
<??>They are inserted in irregular alternation at a basic width B and also at widths 1.5B and 2B. Another type of front stone is box-shaped and therefore permits planting. The anchoring (2) and connecting stones (3) form distance elements with dovetailed projections (7, 8) opposite one another of the same dimensions as the projections (5) of the front stones. By keying of the front stones (1) with these anchoring (2) and connecting stones (3), double-crowned dry walls of various thickness can be erected on the one hand, and retaining walls which can be secured in the slope by re-linking can be erected on the other hand. 
<IMAGE>
Patent IL-92609-A0 (IL)
Title: Substituted imidazole derivatives and their preparation
IPC: A61P3/08
Filed: 1989-12-08
Abstract: Compounds of the formula: <CHEM>  wherein    X is -CH2 - or - @-  Rl is H, alkyl or benzyl, which can be substituted or unsubstituted  R2 is H, alkyl, OH or alkoxy  R3 is H, CH3, CH2CH3, OCH3 or Hal R4 is H, CH3, CH2CH3, OCH3 or Hal and Hal is halogen provided that when R2 is H or C1-3-alkyl then R1 cannot be H and  when R2 is OH or C1-3-alkoxy then X cannot be CO, and non-toxic acid addition salts and mixtures thereof are highly selective antagonists at postsynaptic  alpha 2-adrenoceptors, and are especially useful in the treatment of diabetes.
Patent IL-97249-A0 (IL)
Title: Condensed thiazole compounds,their production and use
IPC: C07D211/76
Filed: 1991-02-15
Abstract: A novel condensed thiazole derivative of the formula [I]: <CHEM> wherein A is a single bond or CH2; R<1> is hydrogen atom, or an optionally substituted aliphatic, carboxylic acyl or sulfonic acyl group; and R<2> is hydrogen atom, or an optionally substituted aromatic cyclic or aliphatic group, or a salt thereof. The compound [I] is useful for medicines for preventing and treating various diseases such as cancer, arterial sclerosis, hepatopathy, cerebrovascular diseases, inflammatory and the like. A process of the compound of the formula [I] or a salt thereof and a pharmaceutical composition comprising the compound of the formula [I] or a pharmaceutically acceptable salt thereof as an active component are also disclosed.
Patent IL-98690-A0 (IL)
Title: Guanidines,their manufacture and pharmaceutical compositions containing them
IPC: A61K31/4433
Filed: 1991-07-01
Abstract: The novel guanidines of the formula 
<IMAGE>
 in which, L, M, R, T and X have the meaning given in the description, and hydrates or solvates thereof, inhibit thrombin-induced platelet aggregation and fibrinogen clotting in the plasma, are prepared by amidination, or by amide formation or esterification, depending on whether L is NH or O.
Patent FI-20080097-A0 (FI)
Inventor: MAJURINEN JOEL
IPC: G06F40/12
Filed: 2008-02-12
Abstract: The object of the invention is a data structure for projects used in data communication in the form of a system that contains mnemonics. In the data structure, the data is stored in a computer in the form of content mnemonics and arrangement mnemonics both containing data. The mnemonics are files stored in relation to each other according to their content. The sequential and/or parallel mnemonics of the mnemonic systems are linked functionally to each other so that the arrangement mnemonics consist of individual search or arrangement information pieces, which are connected to the content mnemonics and on the basis of which the places of the mnemonics are defined in the data structure. The data of the content mnemonics consists of the subject of the project and of ordinary project data. The aim of the project, in which the data structure is used, is e.g. a presentation, education, a communication tool of an enterprise in project management, leadership or a game. In the method provided by the invention, information is searched in the form of different files for a telecommunication network. The files suitable for the data structure are selected on the basis of the actual theme of a project. The files are converted into mnemonics The databases are transformed to be mnemonics according to the content of the files by modifying the data of the files into a mnemonic in a systematic way to present the subject of the project, the unchangeable and changeable data of the project in the content mnemonic. The mnemonics of the system are connected to each other sequentially and/or in parallel so, that the arrangement mnemonic consist of individual search or arrangement data, which is connected to the content mnemonics and on the basis of which the places of the mnemonics are defined in the data structure.
Patent FI-20085276-A0 (FI)
Inventor: PAKKALA DANIEL
IPC: G06F/
Filed: 2008-04-02
Abstract: Node, method and computer program for control of hybrid peer-to-peer systems is disclosed. The node comprises a processor configured to: start a normal operation of the node; check whether a special role is prescribed for the node: if the special role is prescribed for the node, start both a server operation offered to the peer-to-peer system and a control operation of the peer-to-peer system; or else, receive control from a control operation of the peer- to-peer system in the normal operation: if the control is received according to a predetermined rule, continue to receive control from the control operation of the peer-to- peer system in the normal operation; or else, perform a negotiation with the peer-to-peer system, and if the special role is assigned to the node on the basis of the negotiation, start both the server operation offered to the peer-to-peer system and the control operation of the peer- to-peer system.
Patent IL-100502-A0 (IL)
Title: Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogues
IPC: C07D411/04
Filed: 1991-12-25
Abstract: Use of a compound of formula (I) <CHEM> or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of hepatitis B is disclosed.
Patent IL-110040-A0 (IL)
Title: Pyridazinone derivatives
IPC: A61K31/50
Filed: 1994-06-17
Abstract: PCT No. PCT/JP94/01015 Sec. 371 Date Mar. 22, 1996 Sec. 102(e) Date Mar. 22, 1996 PCT Filed Jun. 24, 1994 PCT Pub. No. WO95/01343 PCT Pub. Date Jan. 12, 1995A 3(2H)-pyridazinone derivative of the formula (I) its salt, a process for its production and a pharmaceutical composition containing it.    <IMAGE>  (I)  wherein each of R1, R2 and R3 which are independent of one another, is a hydrogen atom or a C1-4 alkyl group, X is a chlorine atom or a bromine atom, Y1 is a hydrogen atom, a halogen atom, a nitro group, an amino group or a C1-4 alkoxy group, Y2 is a hydrogen atom, a halogen atom, a hydroxyl group, a C1-4 alkyl group or a C1-4 alkoxy group, A is a C1-5 alkylene chain which may be substituted by a hydroxyl group, B is a carbonyl group or a methylene chain which may be substituted by a C1-4 alkyl group, and each of R4 and R5 which are independent of each other, is a C1-4 alkyl group, or R4 is a hydrogen atom and R5 is -Z-Ar (wherein Z is a C1-5 alkylene chain, and Ar is an aromatic 6-membered ring which may contain a nitrogen atom), or R4 and R5 together form a C2-6 cyclic alkylene group, or R4 and R5 form together with the adjacent nitrogen atom a 4-substituted piperazine ring of the formula:   <IMAGE>   wherein R6 is a C1-4 alkyl group.
Patent IL-110189-A0 (IL)
Title: New pharmaceutical formulation
IPC: A61K31/416
Filed: 1994-07-01
Abstract: PCT No. PCT/SE94/00681 Sec. 371 Date Sep. 27, 1994 Sec. 102(e) Date Sep. 27, 1994 PCT Filed Jul. 8, 1994 PCT Pub. No. WO95/01783 PCT Pub. Date Jan. 19, 1995A new oral pharmaceutical formulation containing a novel physical form of a magnesium salt of omeprazole, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
Patent IL-110220-A0 (IL)
Title: Method for the determination of protein and creatinine in aqueous solutions
IPC: G01N33/493
Filed: 1994-07-05
Abstract: Disclosed is a method for the determination of urinary protein and creatinine in a single reaction vessel using a continuous process. The method involves adjusting the pH to a level suitable for carrying out an immuno assay for the protein and making such a determination by an immuno agglutination technique. Raising the pH to a level suitable for determining the creatinine quickly dissipates the cloudiness caused by the agglutination reaction, so that the creatinine determination can be carried out without delay.
Patent IL-110514-A0 (IL)
Title: Concentrates for improving polyester compositions and a method for preparing such compositions
IPC: C08J9/00
Filed: 1994-07-29
Abstract: Disclosed is a concentrate useful as an additive in a polyester composition comprising a polyolefin and a polyfunctional carboxylic acid or polyol branching agent. Also disclosed is a method of preparing a polyester composition having increased melt viscosity and melt strength, and improved impact strength which comprises the steps of A) melt compounding a polyolefin and a polyfunctional carboxylic acid or polyol branching agent, B) dry blending the melt compounded mixture formed in A) with a polyester, and C) molding or extruding the dry blended mixture formed into B) to form an article.
Patent IL-124563-A0 (IL)
Title: Novel indole-2, 3-dione-3-oxime
Inventor: WAETJEN FRANK
IPC: A61P25/00
Filed: 1997-10-01
Abstract: The present invention relates to novel indole-2,3-dione-3-oxime derivatives capable of antagonising the effect of excitatory amino acids, such as glutamate. More specifically the novel indole-2,3-dione-3-oxime derivatives of the invention may be described by general formula (I), wherein R3 represents "Het", or a group of formula (II), wherein "Het" represents a saturated or unsaturated, 4 to 7 membered, monocyclic, heterocyclic ring, at least one of R31, R32, and R33 independendy represents hydrogen, alkyl, or hydroxyalkyl, and at least one of R31, R32, and R33 independently represents (CH2)nR34; wherein R34 represents hydroxy, carboxy, alkoxycarbonyl, alkenyloxycarbonyl, alkynyloxycarbonyl, cycloalkoxycarbonyl, cycloalkylalkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, CONR35R36, or "Het"; wherein n is 0, 1, 2, or 3; and R5 represents phenyl, naphthyl, thienyl, or pyridyl, all of which may be substituted. "A" represents a ring of five to seven atoms fused with the benzo ring at the positions marked "a" and "b", and formed by the following bivalent radicals: a-NR6-CH2-CH2-b; a-CH2-NR6-CH2-b; a-CH2-CH2-NR6-b; a-NR6-CH2-CH2-H2-b; a-CH2-NR6-CH2-CH2-b; a-CH2-CH2-NR6-CH2-b; a-CH2-CH2-CH2-NR6-b; a-NR6-CH2-CH2-CH2-CH2-b; a-CH2-NR6-CH2-CH2-CH2-b; a-CH2-CH2-NR6-CH2-CH2-b; a-CH2&mdas
Patent IL-125867-A0 (IL)
Title: The use of 1-0-alpha-d-glucopyranosyl-d-sorbitol in a confection
IPC: A23G3/00
Filed: 1997-02-21
Abstract: The invention relates to confections, in particular hard and soft confections, which contain a sweetener of 1-O-alpha-D-glucopyranosyl-D-sorbitol (1,1 GPS), in particular 6-O-alpha-D-glucopyranosyl-D-sorbitol (1,6 GPS), 1-O-alpha-D-glucopyranosyl-D-sorbitol (1,1 GPS) and 1-O-alpha-D-glucopyranosyl-D-mannitol (1,1 GPM); and to the use of this sweetener in confections, in particular pharmaceutically active confections.
Patent IL-131520-A0 (IL)
Title: Process for producing stock cubes
IPC: A23P1/00
Filed: 1999-08-22
Abstract: The invention relates to a process for producing stock cubes by mixing the customary constituents comprising salt, fat, extract and, if appropriate, water and also other customary additives, which is characterized in that the mixing is performed by continuous addition of the constituents one after the other in an extruder, an amount of fat which is reduced in comparison with customary formulations of 4-30%, in particular 5-25%, preferably 8-12%, based on the total mixture, being used, the mixture continuously processed in the extruder being extruded through a shaping die to form a dimensionally stable extrudate having a density of 1.0-2.0 g/cm<3>, preferably 1.2-l.7 g/cm<3>, and the extrudate being portioned to the individual pieces which are packaged.
Patent IL-141771-A0 (IL)
Title: Hard layer coated parts
IPC: C23C30/00
Filed: 2001-03-02
Abstract: In hard layer coated parts which are coated with hard layers, this invention aims at improvements of wear resistance, oxidation proof and lubrication properties. In hard layer coated parts which are coated with hard layers, hard layer coated parts featured by hard layers coated with minimum 1-2 layers which contain Al, Ti, Cr, N, O.
Patent IL-146664-A0 (IL)
Title: Connecting devices for catheters, perfusion equipment or liquid draining systems
IPC: A61M39/00
Filed: 2000-06-02
Abstract: The invention comprises an assembly of two external enveloping bodies, open at one end by which they can be coupled to one another so as to slide to a releasable holding position of said enveloping elements, which enveloping elements have, at the opposing ends, respective connections to enable them to communicate with a container or containers containing the liquids to be perfused or to be drained and a connection for the element for perfusion to the patient, said enveloping bodies also having, in their interior, couplable means intended to allow the passage of liquid to be perfused from the inlet conduit to the outlet conduit communicating with the catheter or other perfusion device. <IMAGE>
Patent IL-149782-A0 (IL)
Title: A method for anion-exchange adsorption and thioether anion-exchangers
IPC: B01D15/32
Filed: 2000-11-22
Abstract: A method for the removal of a substance, which has a negative charge and which is present in an aqueous liquid (I). The method comprises the steps of: (i) contacting the liquid with an anion-exchanger (1) that comprises mixed mode anion-exchanging ligands in which there is a positively charged nitrogen allowing binding of the substance to the anion-exchanger; and (ii) desorbing said substance from said anion-exchanger. The characteristic feature is that (A) the mixed mode ligands have a thioether linkage within a distance of 1-7 atoms from their positively charged atom, and (B) the anion-exchanger (1) (i) is capable of binding the substance of interest in an aqueous reference liquid (II) at an ionic strength corresponding to 0.25 M NaCl, and (ii) permits in the pH interval 2-12 a maximal breakthrough capacity for the substance which is ≧200% of the breakthrough capacity of the substance for Q-Sepharose Fast Flow (anion-exchanger 2).
Patent IL-153306-A0 (IL)
Title: Synthesis and of retinoid compounds having negative hormone and/or antagonist activities
IPC: A61K31/381
Filed: 1996-08-23
Abstract: The invention provides a compound of the formula <CHEM>     wherein X is S, O, NR' where R' is H or alkyl of 1 to 6 carbons, or   X is ÄC(R1)2Ün where R1 is independently H or alkyl of 1 to 6 carbons, and n is an integer between 0 and 2; R2 is hydrogen, lower alkyl of 1 to 6 carbons, F, Cl, Br, I, CF3, fluoro substituted alkyl of 1 to 6 carbons, OH, SH, alkoxy of 1 to 6 carbons, or alkylthio of 1 to 6 carbons;   R3 is hydrogen, lower alkyl of 1 to 6 carbons or F;   m is an integer having the value 0-3;   o is an integer having the value 0-3; Y is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazolyl, said phenyl and heteroaryl groups being optionally substituted with one or two R2 groups; A is (CH2)q where q is 0-5, lower branched chain alkyl having 3-6 carbons, cycloalkyl having 3-6 carbons, alkenyl having 2-6 carbons and 1 or 2 double bonds, alkynyl having 2-6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, CONR9R10, -CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, -COR7, CR7(OR12)2, CR7OR13O, or tri-lower alkylsilyl, where R7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons or trimethylsilylalkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R11 is lower alkyl, phenyl or lower alkylphenyl, R12 is lower alkyl, and R13 is divalent alkyl radical of 2-5 carbons, and R14 is (R15)r-phenyl, (R15)r-naphthyl, or (R15)r-heteroaryl where the heteroaryl group has 1 to 3 heteroatoms selected from the group consisting of O, S and N, r is an integer having the values of 0-5, and R15 is independently H, F, Cl, Br, I, NO2, N(R8)2, N(R8)COR8, NR8CON(R8)2, OH, OCOR8, OR8, CN, an alkyl group having 1 to 10 carbons, fluoro substituted alkyl group having 1 to 10 carbons, an alkenyl group having 1 to 10 carbons and 1 to 3 double bonds, alkynyl group having 1 to 10 carbons and 1 to 3 triple bonds, or a trialkylsilyl or trialkylsilyloxy group where the alkyl groups independently have 1 to 6 carbons;   R16 is H, lower alkyl of 1 to 6 carbons;   R17 is H, lower alkyl of 1 to 6 carbons, OH or OCOR11, and p is zero or 1, with the proviso that when p is 1 then there is no R17 substituent group, and m is an integer between 0 and 2.
Patent IL-156876-A0 (IL)
Title: Device and system for in-vivo procedures
IPC: A61B1/313
Filed: 2002-01-11
Abstract: A system for performing in vivo procedures is provided. The system may include a tool for performing an in vivo procedure. The tool may have an in vivo sensor for obtaining in vivo information; a functional element for performing an interventional or diagnostic in-vivo procedure; a processor in communication with the tool for receiving and optionally processing the in vivo information obtained by the tool and a monitor in communication with the processor for displaying the optionally processed in vivo information. The communication between the elements of the system may be wireless, or, optionally, wired.